Introduction
Methods
Search strategy and study selection
Data extraction
Evaluation methods
Statistical analysis
Results
Year | Authors | Type of Article | Sample Size | Population of interest | Entheses sites of interest | Face validity |
---|---|---|---|---|---|---|
1987
| Maffulli [42] | case series | 47 | Athletes | A | N |
1989
| Olivieri [47] | case report | 1 | SPA | A, PF, ischial tuberosity, trochanter | N |
1994
| Lehtinen [40] | case control | 39 | SPA (ReA, PsA, AS) | pelvic adductor origin, trochanter, ischial tuberosity, PT, A, PF | N |
1995
| Lehtinen [39] | cohort | 23 | SPA | ischial tuberosity, trochanter, PT, A, PF | N |
1998
| Olivieri [46] | case series | 14 | SPA | A (hanging free over the edge of the table) | N |
1999
| Gibbon [32] | case control | 370 | clinically idiopathic plantar fasciitis, SPA, RA, Achilles tendon disease, ankle instability, healthy subjects | A, PF (90°) | N |
2000
| Balint [17] | case report | 1 | PsA | A (hanging free) | N |
2000
| Galluzzo [29] | case series | 31 | PsA | A, PF | N |
2001
| Cosentino [19] | RCT | 60 | patients with talalgia | PF | N |
2002
| Balint [16] | case series | 35 | SPA (AS, PsA, ReA) | GUESS score: A, PF (90°),PTPI, PTDI, Q (30°) | N |
2002
| D'Agostino [21] | case report | 2 | SPA | A, PF | N |
2002
| Falsetti [10] | case control | 450 | SPA ,RA, OA, painful shoulders, healthy subjects | Deltoid tendon insertion | N |
2002
| Falsetti [28] | case control | 178 | PMR, SPA(PsA, AIBD, uSpA), RA | wrist, elbow, shoulder, hip, knee, ankle, heel | N |
2002
| Frediani [27] | case control | 160 | PsA, RA, healthy subjects | Q (30°) | N |
2003
| D'Agostino [22] | case control | 228 | SPA, MBP, RA | A, PF, tibialis anterior tendon, CET, FCT, PT, Q, gluteus medius and minimus tendons | N |
2003
| De Simone [24] | case control | 109 | psoriatic with arthritis or spondylitis, healthy subjects | A | N |
2003
| Falsetti [11] | case control | 598 | EOA , NOA , RA, PsA, healthy subjects | A, PF | N |
2003
| Kamel [34] | case series | 32 | SPA | A, PF | Y |
2004
| Falsetti [9] | case control | 157 | CCA, OA, healthy subjects | A, PF | N |
2004
| Kamel [35] | case series | 16 | SPA | PT | N |
2005
| Genc [30] | case control | 62 | RA , AS, healthy subjects | * | N |
2005
| Ozçakar [48] | case control | 50 | Psoriasis, healthy subjects | A (Neutral flexion) | N |
2005
| Ozgocmen [49] | case report | 1 | AS | A | N |
2005
| Wakefield [52] | consensus | - | NA | NA | N |
2006
| Borman [18] | case series | 44 | SPA (AS, PsA, ReA, uSpA) | A, PF | N |
2006
| Fournie [26] | case control | 41 | PsA, RA | flexor tendons of the hand | N |
2006
| Kiris [37] | case series | 30 | AS | MASES ** | N |
2006
| Tse [51] | case report | 1 | AS | A, PF, Q, PT | N |
2007
| Alcalde [14] | case control | 54 | AS, healthy subjects | A(neutral flexion), PF (neutral flexion),PTPI(60°), PTDI (60°), Q (60°) | N |
2007
| Genc [31] | cohort | 54 | RA, AS | GUESS * | N |
2007
| Kerimoglu [36] | case series | 49 | Hemodialysis | GUESS * | N |
2007
| Scarpa [50] | case control | 47 | PsA , "sine psoriasis"patients | All entheses with increased tracer uptake in scintigraphy | N |
2007
| Wiell [53] | case control | 20 | PsA, RA, healthy subjects | flexor/extensor tendons of the hands | Y |
2008
| de Miguel [23] | case control | 54 | SPA(AS, ReA, uSpA, PsA, juvenile SPA), healthy subjects | MASEI score: A (90°), PF (90°), PTPI (70°), PTDI (70°), Q, brachial triceps tendon (90°) | N |
2008
| Filippou [12] | case series | 7 | Ochronosis | flexor/extensor tendon of the hand, CET, CFT, distal brachial triceps tendon, gluteus medius and minimus tendons, Q, PT, iliotibial band, A, PF, anterior and posterior tibialis tendon, peroneal tendon, toe extensor tendon | N |
2008
| Gisondi [33] | case control | 60 | Psoriasis, healthy subjects | GUESS * | N |
2008
| Hatemi [7] | case control | 160 | Behçet, AS, RA, healthy control | GUESS * | Y |
2008
| Klauser [38] | case control | 33 | SPA (AS, PsA, uSpA, ReA, AIBD), RA, patients with non rheumatic disease | MASES ** | N |
2008
| Mc Gonagle [44] | case control | 47 | SPA(AS, PsA, ReA), healthy subjects | A (90°) | N |
2009
| D'Agostino [20] | case series | 5 | SPA(AS, uSpA, PsA, AIBD) | Q, PTPI , CET, A, PF | N |
2009
| Filippucci [13] | case series | 28 | SPA | A (hanging in neutral position) | N |
2009
| Matsos [43] | case series | 62 | NA | NA | N |
2009
| Munoz-Fernandez [45] | case control | 79 | SPA, anterior uveitis, healthy subjects | MASEI *** | N |
2009
| Filippucci [25] | case series | NA | PsA | A | N |
2009
| Iagnocco [8] | case series | 93 | SPA | A(hanging in neutral position) | N |
2010
| Gutierrez [6] | case series | 30 | PsA | U: A, Apo, PT | N |
2010
| Li [41] | case control | 70 | SPA(AS, ReA, PsA,AIBD, uSpA), healthy subjects | A (90°) | N |
2010
| Aydin [15] | Case series | 43 | SPA | A (hanging in neutral position) | N |
Ultrasound parameters and setting
Definition and description of enthesitis in grey-scale and Doppler modes
Lear | Authors | Grey-scale | Doppler | Definition or description of Enthesitis ♣ | Elementary components | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Echogenicity | Thickness | Calcific Deposits | Enthesophytes | Tear | Erosions | Cortical Irregularities | Bursitis | |||||
1987
| Maffulli [42] | Y | NA | Y | Y | Y | Y | NA | NA | NA | NA | NA |
1989
| Olivieri [47] | Y | NA | NA | NA | Y | NA | NA | NA | NA | NA | NA |
1994
| Lehtinen [40] | Y | NA | Y | U | Y | Y | Y | NA | NA | U | Y |
1995
| Lehtinen [39] | Y | NA | Y | U | Y | Y | Y | NA | NA | U | NA |
1998
| Olivieri [46] | Y | NA | NA | Y | Y | NA | NA | NA | NA | NA | NA |
1999
| Gibbon [32] | Y | NA | Y | Y | Y | Y | Y | NA | Y | NA | NA |
2000
| Balint [17] | Y | Y | NA | NA | Y | NA | NA | NA | NA | NA | Y |
2000
| Galluzzo [29] | Y | NA | Y | Y | Y | Y | NA | NA | NA | NA | NA |
2001
| Cosentino [19] | Y | NA | Y | Y | Y | NA | Y | NA | NA | NA | NA |
2002
| Balint [16] | Y | NA | Y | Y | Y | NA | Y | NA | Y | Y | Y |
2002
| D'Agostino [21] | Y | Y | NA | Y | Y | Y | NA | NA | Y | NA | NA |
2002
| Falsetti [10] | Y | NA | Y | Y | Y | NA | Y | NA | Y | Y | NA |
2002
| Falsetti [28] | Y | NA | Y | Y | Y | NA | Y | NA | Y | NA | NA |
2002
| Frediani [27] | Y | NA | Y | Y | Y | NA | Y | NA | Y | Y | NA |
2003
| D'Agostino [22] | Y | Y | NA | Y | Y | Y | U | U | Y | Y | NA |
2003
| De Simone [24] | Y | NA | NA | Y | Y | Y | NA | Y | NA | NA | Y |
2003
| Falsetti [11] | Y | NA | Y | Y | Y | Y | Y | NA | Y | NA | Y |
2003
| Kamel [34] | Y | NA | Y | Y | Y | Y | Y | Y | NA | NA | NA |
2004
| Falsetti [9] | Y | Y | Y | Y | Y | NA | Y | NA | Y | NA | NA |
2004
| Kamel [35] | Y | NA | Y | Y | Y | Y | NA | NA | NA | NA | Y |
2005
| Genc [30] | Y | NA | Y | Y | Y | NA | Y | NA | Y | NA | Y |
2005
| Ozçakar [48] | Y | NA | NA | U | Y | U | U | U | U | U | Y |
2005
| Ozgocmen [49] | U | Y | NA | NA | U | NA | NA | NA | NA | NA | NA |
2005
| Wakefield [52] | Y | Y | Y | Y | Y | Y | Y | NA | Y | Y | NA |
2006
| Borman [18] | Y | NA | Y | Y | Y | NA | Y | NA | Y | NA | Y |
2006
| Fournie [26] | Y | NA | Y | NA | NA | NA | Y | NA | NA | NA | NA |
2006
| Kiris [37] | Y | Y | NA | Y | Y | Y | Y | U | Y | Y | Y |
2006
| Tse [51] | Y | NA | NA | NA | U | U | U | U | U | U | U |
2007
| Alcalde [14] | Y | NA | Y | Y | Y | Y | NA | Y | Y | NA | Y |
2007
| Genc [31] | Y | NA | Y | Y | Y | NA | Y | NA | Y | NA | Y |
2007
| Kerimoglu [36] | Y | NA | Y | Y | Y | Y | Y | NA | Y | NA | Y |
2007
| Scarpa [50] | Y | Y | Y | Y | Y | Y | Y | NA | Y | Y | NA |
2007
| Wiell [53] | Y | Y | Y | Y | Y | Y | Y | NA | Y | Y | NA |
2008
| de Miguel [23] | Y | Y | NA | Y | Y | Y | Y | NA | Y | NA | Y |
2008
| Filippou [12] | Y | Y | Y | Y | Y | Y | NA | NA | NA | NA | NA |
2008
| Gisondi [33] | Y | NA | Y | Y | Y | NA | Y | NA | Y | NA | Y |
2008
| Hatemi [7] | Y | Y | Y | Y | Y | NA | Y | NA | Y | Y | Y |
2008
| Klauser [38] | Y | Y | Y | Y | Y | NA | Y | NA | Y | NA | NA |
2008
| McGonagle [44] | Y | NA | Y | Y | Y | NA | Y | NA | Y | NA | NA |
2009
| D'Agostino [20] | Y | Y | Y | Y | Y | Y | Y | NA | Y | NA | NA |
2009
| Filippucci [13] | Y | Y | Y | Y | Y | Y | Y | NA | Y | Y | Y |
2009
| Matsos [43] | Y | Y | Y | Y | Y | Y | Y | NA | Y | Y | NA |
2009
| Munoz-Fernandez [45] | Y | Y | NA | Y | Y | Y | Y | NA | Y | NA | Y |
2009
| Filippucci [25] | Y | Y | Y | Y | Y | N | Y | NA | Y | NA | Y |
2009
| Iagnocco [8] | Y | Y | Y | Y | Y | Y | Y | NA | Y | Y | Y |
2010
| Gutierrez [6] | Y | Y | Y | Y | Y | N | Y | NA | Y | NA | Y |
2010
| Li [41] | Y | Y | Y | Y | Y | N | N | NA | Y | Y | NA |
2010
| Aydin [15] | Y | Y | Y | Y | Y | Y | Y | NA | Y | Y | Y |
Year | Authors | Doppler parameters | Description of site of vascularization |
---|---|---|---|
2000 | Balint [17] | PRF1000 Hz | NA |
2002 | D'Agostino [21] | PRF 750 Hz, power Doppler gain 50 | periosteal bone and enthesis |
2003 | D'Agostino [22] | PRF 750 Hz, power Doppler gain 50-53dB | cortical bone insertion, body of the tendon, bursa, junction tendon/enthesis |
2004 | Falsetti [9] | PRF 750-1000 Hz, highest gain level without background noise and low filter | tendon + bursa |
2005 | Ozgocmen [49] | PRF 0.3-1.5kHz, dynamic range 55dB low wall filter | periosteum and achilles tendon insertion |
2005 | Wakefield [52] | NA | NA |
2006 | Kiris [37] | PRF 0.5-1 KHz , dynamic range 50-55dB - low wall filter | tendon + enthesis : no precision concerning the exact location of vascularization |
2007 | Scarpa [50] | NA | NA |
2007 | Wiell [53] | PRF 500 Hz | NA |
2008 | De Miguel [23] | PRF 400Hz, gain 20dB, low wall filter | enthesis, tendon, bursitis |
2008 | Filippou [12] | NA | NA |
2008 | Hatemi [7] | PRF 750 Hz | NA |
2008 | Klauser [38] | 8.3 MHz, PRF 500 Hz, low wall filter | NA |
2009 | D'Agostino [20] | 10 MHz, PRF 500 Hz, gain 113 dB | enthesis insertion into the cortical bone |
2009 | Filippucci [13] | PRF 750 Hz, colour-mode frequency of 9.1 MHz , low wall filters | enthesis, tendon, bursitis |
2009 | Matsos [43] | NA | U |
2009 | Munoz-Fernandez [45] | NA | enthesis, tendon, bursitis |
2009 | Filippucci [25] | NA | U |
2009 | Iagnocco [8] | PRF 900Hz , Doppler frequency 9.1 MHz, low wall filters | enthesis, tendon, bursitis |
2010 | Gutierrez [6] | PRF750 Hz , Doppler frequency between 7.5 -14.3 MHz. | U |
2010 | Li [41] | 10 MHz for colour-mode scanning with a focus at 5 mm. | peri-sesamoidal and periosteal areas |
2010 | Aydin [15] | PRF 750 Hz, colour-mode frequency of 9.1 MHz, low wall filters | enthesis, tendon, bursitis |
Scoring system of enthesitis (grey-scale and Doppler)
Year | Authors | Enthesis studied | Grey-scale | Doppler mode | Scoring system | Reliability | Sensitivity to change |
---|---|---|---|---|---|---|---|
2001
| Cosentino [19] | PF | Y | N | grade l: thickening of enthesis (<2 mm thicker than the controlateral asymptomatic side), heterogeneous hypoechogenicity of enthesis and enthesophytosis. grade 2: thickening of enthesis (>2 mm thicker than the controlateral asymptomatic side), heterogeneous hypoechogenicity of enthesis, and enthesophytosis. grade 3: grade 2 with peritendinous oedema. | NA | U |
2002
| Balint [16] | GUESS: A, PF (90°),PTPI, PTDI, Q (30°) | Y | N | GUESS score (0 to 36): Each item scores one point. total possible score on both lower limb is 36 superior pole of the patella- quadriceps tendon enthesis: quadriceps tendon thickness >=6.1mm, suprapatellar bursitis, superior pole of patella erosion, superior pole of patella enthesophyte inferior pole of the patella-proximal patellar ligament enthesis: patellar ligament thickness > = 4 mm, inferior pole of patella erosion, inferior pole of patella enthesophyte tibial tuberosity-distal patellar ligament enthesis: patellar ligament thickness > = 4 mm, infrapatellar bursitis, tibial tuberosity erosion, tibial tuberosity enthesophyte superior pole of the calcaneus-achilles tendon enthesis: Achilles tendon thickness >=5.29 mm, retrocalcaneal bursitis, posterior pole of calcaneus erosion, posterior pole of calcaneus enthesophyte inferior pole of the calcaneus -plantar aponeurosis enthesis: Plantar aponeurosis thickness >=4.4 mm, inferior pole of calcaneus erosion, inferior pole of calcaneus enthesophyte. | U | NA |
2002
| Falsetti [28] | wrist, elbow, shoulder, hip, knee, ankle, calcaneum | Y | N | each item scored according to a semi quantitative score: 1: mild,2: moderate,3:considerable items scored: synovitis, tenosynovitis, enthesitis | U | NA |
2003
| D'Agostino [22] | A, PF, tibialis anterior tendon, CET, CFT, PT, Q, trochanter | Y | Y | stage 1: Vascularization at the cortical junction without abnormal findings in Grey-scale stage 2a: Vascularization associated with swelling and/or decreased echogenicity at the cortical junction in Grey-scale stage 3a: Same as stage 2a, plus erosions of cortical bone and/or calcification of enthesis, and optional surrounding bursitis stage 2b: Abnormal findings in B mode as in stage 2a, but without vascularization stage 3b: Abnormal findings in B mode as in stage 3a, but without vascularization | Y | NA |
2003
| Falsetti [11] | A, PF, retrocalcaneal bursae, subcalcaneal fat pad, cortical bone of posterior and inferior aspects of calcaneum | Y | N | Each inflammatory lesion was graded according to a semi-quantitative scale: grade 1: mild, grade 2: moderate, grade 3: considerable | NA | NA |
2006
| Kiris [37] | MASES * | N | Y | 0 = absence, 1 = mild, 2 = moderate, 3 = severe | Y | NA |
2007
| Alcalde [14] | SEI: A, PF (neutral flexion°),PTPI, PTDI, Q (60°) | Y | N | SEI = the total sum of SEI-A and SEI-C. the maximum SEI scoring is 76 points SEI-A (0 to 36): each variable is scored as 0 (absence) or 1 (presence): thickening of tendon/aponeurosis, hypoechogenicity of tendon/aponeurosis, peritendinous/periaponeurotic oedema, bursitis (where applicable) SEI-C (0 to 40): each variable is scored as 0 (absence) or 1 (presence): tendon tear, loss of thickness, tendon calcification, bone erosion. | U | NA |
2008
| De Miguel [23] | MASEI: A (90°), PF (90°), PTPI and PTDI (70°), distal Q tendon, distal brachial triceps tendon (90°) | Y | Y | MASEI score (0 to 136 on both sides): Calcifications were scored on a semi-quantitative score of 0 to 3 Doppler and erosions were scored as 0 or 3 points Scores for tendon structure, tendon thickness and bursa were either 0 or 1. Calcifications were examined at the area of the enthesis insertion, and scored as 0 if absent, or 1 if a small calcification or ossification with an irregularity of enthesis cortical bone profile was seen. Calcifications were given a score of 2 if there was clear presence of enthesophytes or if medium sized calcifications or ossification were observed. Lastly, they were classified as a 3 if large calcifications or ossifications were present. To simplify things, ossifications and enthesophytes at the enthesis were also included as calcifications. | Y | NA |
2008
| Hatemi [7] | GUESS ** | Y | Y | GUESS score* + Doppler: one point for each enthese with vascularization. Cumulative score for Doppler (max = 10) | U | NA |
2009
| D'Agostino [20] | Q, PTPI, CET, A, PF | Y | Y | Grey-scale: hypoechogenicity/thickness: 0 to 1, calcification/enthesophyte: 0 to 1, erosion: 0 to 1 Doppler : (0 to 3): 0: no signal, 1: minimal (1 spot), 2: moderate (2 spot), 3: severe (> = 3 spots)or Doppler scored as 0 to 1 (absent-present) | Y | NA |
2008
| Mc Gonagle [44] | A (90°) | Y | N | spur (0 to 3):0 absence, 1: minimal, 2: moderate, 3: large | NA | NA |
2009
| Filippucci [13] | A | Y | Y | soft tissue inflammation (seven items): tendon hypoechogenicity, Entheseal hypoechogenicity, Bursal effusion, PDS signal at tendon level, PDS signal at entheseal level, PDS signal at bursal level tissue damage (five items): Intratendineous calcifications, Entheseal calcifications, Enthesophytes, Bone erosions, Bone irregularities* (not used to calculate total score) (1) a total score for soft tissue inflammation, which resulted from the sum of the scores assigned to the 7 US findings indicative of soft tissue inflammation, ranging from 0 to 7 with presence/absence data and from 0 to 14 with semiquantitative scores; (2) a total score for tissue damage, which resulted from the sum of the scores assigned to the 4 US findings indicative of tissue damage, ranging from 0 to 4 with presence/absence data and from 0 to 8 with semiquantitative scores. | Y | NA |
2009
| Iagnocco [8] | A (neutral position) | Y | Y | All lesions scored on both a dichotomous scale (present/absent) and a 4-point semiquantitative scale (0 = absent, 1 = mild, 2 = moderate, 3 = severe) enthesopathy: tendon hypoechogenicity at the level of bony attachment, tendon thickening at the at the level of bony attachment, intra-tendinous calcifications, enthesophytes, bony erosions, bony cortex irregularities, presence of Doppler signal at the level of bony attachment, presence of intratendinous Doppler signal bursitis: enlargement of deep calcaneal bursa, enlargement of superficial calcaneal bursa tendon lesion: both partial and full-thickness tendon lesions | NA | NA |
Evaluation of studies according to the OMERACT filter
Year | Authors | Blinded design | Reliability | Construct validity | Criterion validity | Comparator | Responsiveness |
---|---|---|---|---|---|---|---|
1987
| Maffulli [42] | NA | NA | NA | NA | N | N |
1989
| Olivieri [47] | NA | NA | NA | NA | N | NA |
1994
| Lehtinen [40] | Y | NA | Y | NA | clinical | NA |
1995
| Lehtinen [39] | Y | NA | NA | NA | N | N |
1998
| Olivieri [46] | Y | NA | Y | NA | MRI, clinical | NA |
1999
| Gibbon [32] | N | NA | NA | NA | N | NA |
2000
| Balint [17] | N | NA | NA | NA | N | Y |
2000
| Galluzzo [29] | Y | NA | Y | NA | Xrays, clinical | NA |
2001
| Cosentino [19] | Y | NA | Y | NA | Xrays | Y |
2002
| Balint [16] | Y | U | Y | NA | clinical | NA |
2002
| D'Agostino [21] | NA | NA | NA | NA | N | Y |
2002
| Falsetti [10] | Y | NA | Y | NA | clinical and Xrays | NA |
2002
| Falsetti [28] | Y | Inter | NA | NA | N | NA |
2002
| Frediani [27] | Y | NA | Y | NA | clinical | NA |
2003
| D'Agostino [22] | Y | Intra and inter | Y | NA | clinical | NA |
2003
| De Simone [24] | NA | NA | Y | NA | clinical | NA |
2003
| Falsetti [11] | Y | NA | Y | NA | Xrays | NA |
2003
| Kamel [34] | Y | Intra and inter | Y | NA | MRI | NA |
2004
| Falsetti [9] | Y | NA | Y | NA | clinical | NA |
2004
| Kamel [35] | NA | NA | Y | NA | MRI | NA |
2005
| Genc [30] | Y | NA | NA | NA | N | NA |
2005
| Ozçakar [48] | NA | NA | NA | NA | N | NA |
2005
| Ozgocmen [49] | NA | NA | NA | NA | N | Y |
2005
| Wakefield [52] | NA | NA | NA | NA | N | NA |
2006
| Borman [18] | Y | NA | Y | NA | clinical | NA |
2006
| Fournie [26] | NA | NA | NA | NA | N | NA |
2006
| Kiris [37] | Y | Intra | Y | NA | clinical | NA |
2006
| Tse [51] | NA | NA | Y | NA | MRI | Y |
2007
| Alcalde [14] | Y | Inter | NA | NA | N | NA |
2007
| Genc [31] | Y | NA | NA | NA | N | N |
2007
| Kerimoglu [36] | NA | NA | NA | NA | N | NA |
2007
| Scarpa [50] | Y | NA | NA | NA | N | NA |
2007
| Wiell [53] | Y | Inter | Y | NA | MRI | NA |
2008
| de Miguel [23] | Y | Inter | NA | NA | N | NA |
2008
| Filippou [12] | NA | NA | NA | NA | N | NA |
2008
| Gisondi [33] | Y | U | Y | NA | Xrays | NA |
2008
| Hatemi [7] | Y | Inter | Y | NA | clinical | NA |
2008
| Klauser [38] | Y | NA | Y | NA | clinical | NA |
2008
| Mc Gonagle [44] | Y | NA | NA | Y | histology | NA |
2009
| D'Agostino [20] | Y | Intra and inter | NA | NA | N | NA |
2009
| Filippucci [13] | Y | Inter | NA | NA | N | NA |
2009
| Matsos [43] | NA | NA | NA | NA | N | NA |
2009
| Munoz-Fernandez [45] | Y | U | NA | NA | N | NA |
2009
| Filippucci [25] | NA | NA | NA | NA | N | NA |
2009
| Iagnocco [8] | Y | NA | NA | NA | N | NA |
2010
| Gutierrez [6] | NA | NA | NA | NA | N | NA |
2010
| Li [41] | NA | NA | NA | NA | N | NA |
2010
| Aydin [15] | NA | Intra | NA | NA | N | Y |